99 related articles for article (PubMed ID: 26416045)
21. TIMP-2 G-418C polymorphism and cancer risk: A meta-analysis.
Zhang S; Gao X; Yang J; Ji Z
J Cancer Res Ther; 2015; 11(2):308-12. PubMed ID: 26148591
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis.
Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
Exp Ther Med; 2011 Sep; 2(5):931-936. PubMed ID: 22977600
[TBL] [Abstract][Full Text] [Related]
23. [Cyclooxygenase-2 -765G>C polymorphism and susceptibility to colorectal cancer: a meta-analysis].
Chen X; Dong W; Wang J; Lyu X; Lei H; Liu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Jan; 48(1):62-6. PubMed ID: 24713293
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis.
Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
Genet Mol Res; 2011 Oct; 10(4):3674-88. PubMed ID: 22058001
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer.
Mishra K; Behari A; Kapoor VK; Khan MS; Prakash S; Agrawal S
J Gastroenterol Hepatol; 2013 Oct; 28(10):1678-85. PubMed ID: 23962084
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor -634 G/C polymorphism and risk of cancer: an updated meta-analysis.
Ban JY; Shin JI; Oh CH
Genet Mol Res; 2015 Oct; 14(4):13906-14. PubMed ID: 26535706
[TBL] [Abstract][Full Text] [Related]
27. Association between Polymorphisms in Vascular Endothelial Growth Factor Gene and Response to Chemotherapies in Colorectal Cancer: A Meta-Analysis.
Wang L; Ji S; Cheng Z
PLoS One; 2015; 10(5):e0126619. PubMed ID: 25955730
[TBL] [Abstract][Full Text] [Related]
28. Lack of association between the aryl hydrocarbon receptor rs2066853 polymorphism and breast cancer: A meta-analysis on Ahr polymorphism and breast cancer.
Li Y; Qin HZ; Song Q; Wu XD; Zhu JH
Genet Mol Res; 2015 Dec; 14(4):16162-8. PubMed ID: 26662408
[TBL] [Abstract][Full Text] [Related]
29. The association between vascular endothelial growth factor (VEGF) +405G>C genetic polymorphism and endometriosis.
Fang F; Gong L; Wang X; Zhang L
Exp Biol Med (Maywood); 2015 Sep; 240(9):1177-82. PubMed ID: 25573961
[TBL] [Abstract][Full Text] [Related]
30. Association of rs2233678 and rs2233679 polymorphisms in the PIN1 gene with cancer risk: a meta-analysis.
Zhenzhen L; Ning S; Xianghua L
Tumour Biol; 2014 Jan; 35(1):433-40. PubMed ID: 23982872
[TBL] [Abstract][Full Text] [Related]
31. Association between BRCA1 rs799917 polymorphism and breast cancer risk: A meta-analysis of 19,878 subjects.
Qin TT; Chen T; Zhang Q; Du HN; Shu YQ; Luo K; Zhu LJ
Biomed Pharmacother; 2014 Sep; 68(7):905-10. PubMed ID: 25194442
[TBL] [Abstract][Full Text] [Related]
32. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S; Bahari G; Mashhadi MA; Taheri M
Cancer Biomark; 2014; 14(5):343-51. PubMed ID: 25171476
[TBL] [Abstract][Full Text] [Related]
34. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
[TBL] [Abstract][Full Text] [Related]
35. HOGG1 Ser326Cys polymorphism and susceptibility to head and neck cancer: a meta-analysis.
Liu J; Cao XL; Zhang Z; Lei DP; Jin T; Yu XM; Pan XL
Asian Pac J Cancer Prev; 2011; 12(10):2491-4. PubMed ID: 22320944
[TBL] [Abstract][Full Text] [Related]
36. Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis.
Hou Q; Li MY; Huang WT; Wei FF; Peng JP; Lou MW; Qiu JG
Oncotarget; 2017 Jul; 8(30):50061-50070. PubMed ID: 28562357
[TBL] [Abstract][Full Text] [Related]
37. Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies.
Li Q; Liu L; Liu Y; Zhou H; Yang Z; Yuan K; Min W
Med Oncol; 2015 Jan; 32(1):397. PubMed ID: 25433948
[TBL] [Abstract][Full Text] [Related]
38. Association between the XRCC6 Promoter rs2267437 polymorphism and cancer risk: evidence based on the current literature.
Xu H; Zou P; Chen P; Zhao L; Zhao P; Lu A
Genet Test Mol Biomarkers; 2013 Aug; 17(8):607-14. PubMed ID: 23745766
[TBL] [Abstract][Full Text] [Related]
39. Association between the PPARγ Pro12Ala polymorphism and risk of gestational diabetes mellitus: a meta-analysis.
Shuai HL; Lin XZ; Chen DL; Li P; Luo X
Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819738
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphism 8q24 rs13281615 and risk of breast cancer: meta-analysis of more than 100,000 cases.
Gong WF; Zhong JH; Xiang BD; Ma L; You XM; Zhang QM; Li LQ
PLoS One; 2013; 8(4):e60108. PubMed ID: 23565189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
